Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis
NCT00226707 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 652
Last updated 2008-02-15
Summary
Topical steroids are standard of care for Chronic Hand Dermatitis, but long-term use is associated with adverse effects. This study will assess the efficacy and safety of pimecrolimus cream 1% in patients with mild-to-moderate chronic hand dermatitis.
Conditions
- Chronic Hand Dermatitis
Interventions
- DRUG
-
Pimecrolimus Cream 1%
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals Japan · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Completion
- 2005-03-31
More Related Trials
-
Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion
NCT00925730 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients
NCT00121316 ·Status: COMPLETED ·Phase: PHASE4
-
Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis
NCT00367393 ·Status: COMPLETED ·Phase: PHASE4
-
Pimecrolimus and Epidermal Barrier Function
NCT01132079 ·Status: COMPLETED ·Phase: NA
-
Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema
NCT00946478 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis
NCT00150059 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis
NCT00379678 ·Status: COMPLETED
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
NCT02118766 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects
NCT00139581 ·Status: COMPLETED ·Phase: PHASE4
-
Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis
NCT00351052 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
NCT00919763 ·Status: COMPLETED ·Phase: PHASE2
-
A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis
NCT00484003 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting
NCT00509990 ·Status: COMPLETED ·Phase: PHASE4
-
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
NCT00568997 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children
NCT00810862 ·Status: TERMINATED ·Phase: PHASE4
-
CT 327 in the Treatment of Atopic Dermatitis
NCT00996008 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old
NCT00510003 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
NCT01652885 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life Study in Adults With Facial Eczema
NCT00120302 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
NCT07073677 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema
NCT05486117 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
NCT05729074 ·Status: UNKNOWN ·Phase: PHASE1
-
Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
NCT00076375 ·Status: COMPLETED ·Phase: PHASE2